Denmark to Restrict Ozempic, Other GLP-1 Drugs, to Treat Type 2 Diabetes
Denmark will start putting patients suffering from type 2 diabetes on cheaper drugs before prescribing so-called GLP-1 drugs such as Novo Nordisk's Ozempic, the Danish...
Stay updated with breaking news from Eli Lilly Trulicity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Denmark will start putting patients suffering from type 2 diabetes on cheaper drugs before prescribing so-called GLP-1 drugs such as Novo Nordisk's Ozempic, the Danish...
Denmark will start putting patients suffering from type 2 diabetes on cheaper drugs before prescribing so-called GLP-1 drugs such as Novo Nordisk's Ozempic, the Danish Medicines Agency said on Wednesday. In 2023, 50% of new patients suffering from type 2 diabetes began treatment with a reimbursed GLP-1 drug without trying a cheaper alternative first, the Medicines Agency said. Demand for Novo Nordisk's diabetes drug Ozempic has soared as many people have started using the diabetes drug for its weight-loss effects.
The European Medicines Agency announced the findings of its nine-month review
By Dominic Chopping The European Union's drug regulator found no link between the class of medicines behind Novo Nordisk's blockbuster Ozempic and Wegovy treatments and reports of suicidal...
The FDA earlier this year found no evidence that Ozempic and similar weight loss drugs cause suicidal thoughts or actions